Skip Ribbon Commands
Skip to main content



EMEA Bio-Pharma Digest Q2 2011

Our latest sector analysis reviews key trends and themes within the LifeSciences sector. This sector continues to witness a slew of consolidation and M&A activity, increasing industry collaboration, entry into emerging markets and continued restructuring and rationalisation.
All of these trends will have clear implications for the real estate portfolios of Life Sciences companies across the globe.

Please fill out the form to download the report.

pdf | 343571